Cedar Brook Financial Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cedar Brook Financial Partners's LLY Position: Q3 2024 in Review
Cedar Brook Financial Partners sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 404 shares — an estimated $366K sold.
Cedar Brook Financial Partners first reported a position in LLY in Q1 2019 and held it in 18 quarters. The position peaked at $1.2M in Q1 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.
- Cedar Brook Financial Partners reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
- Cedar Brook Financial Partners sold 404 Eli Lilly shares in Q3 2024, an estimated $366K.
- Cedar Brook Financial Partners first reported a position in Eli Lilly in Q1 2019 and held it in 18 quarters.
- Cedar Brook Financial Partners's Eli Lilly position peaked at $1.2M in Q1 2024.
- 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.
Based on Cedar Brook Financial Partners's 13F filing for Q3 2024, filed 21 Oct 2024.